The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of HLA class 1 homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer (NSCLC) treated with PD-1 inhibitor as first-line therapy.
 
Young Kwang Chae
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Counsyl; Foundation Medicine; Guardant Health; Hanmi; Immuneoncia; Lilly; Roche/Genentech; Takeda; Tempus
Speakers' Bureau - AstraZeneca; Genentech/Roche; Lilly; Merck
Research Funding - Abbvie; Biodesix; Bristol-Myers Squibb; Freenome; Lexent Bio
Travel, Accommodations, Expenses - Hanmi
 
Dongyup Lee
No Relationships to Disclose
 
Jonghanne Park
Employment - Novartis (I)
 
Horyun Choi
No Relationships to Disclose
 
Gahyun Gim
No Relationships to Disclose
 
Sukjoo Cho
No Relationships to Disclose
 
Leeseul Kim
No Relationships to Disclose
 
Youjin Oh
No Relationships to Disclose
 
Cyra Y Kang
No Relationships to Disclose
 
Pedro Antonio Hermida de Viveiros
No Relationships to Disclose